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with severity of depressive symptoms (table). This significant association persisted after
adjustment for traditional CAD risk factors. In contrast, lifetime history of major depres-
sion was not significantly associated with HRV in the absence of current depressive
symptoms. In conclusion, increasing levels of depressive symptoms are associated with
decreased HRV in individuals free of CAD. In this group, autonomic dysfunction, as
reflected by decreased HRV, is a plausible mechanism linking depression to CAD.
1072-216 Evaluation of QRS Wave Residuum and Risk of Sudden 
Cardiac Death
Yi Gang, Katerina Hnatkova, Juan Gimeno, Marek Malik, St. George's Hospital Medical 
School, London, United Kingdom
Background: This study investigated the association between QRS wave residuum
(QRSr) from standard 12-lead ECG and risk factors (RF) (i.e. previous cardiac arrest,
non-sustained ventricular tachycardia on Holter monitoring, abnormal exertional blood
pressure response (ABPR), unexplained syncope, a family history of premature sudden
cardiac death (SD), and maximum left ventricular wall thickness (MLVWT) >30 mm) for
SD in patients (pts) with hypertrophic cardiomyopathy (HC).
Methods: Ten consecutive 12-lead ECGs were recorded from each of 157 HC pts (107
men, age 43±15, 14-79 yrs) using a digital electrocardiograph (MACVU, GE Medical Sys-
tems, WI, USA) with a sampling rate of 500 Hz. Study pts were followed up for 60±44
months. Analysis of the digital ECG recordings was performed in a fully automatic man-
ner with custom-developed software implemented on a personal computer. Non-dipolar
ECG components are considered to reflect the local electrical heterogeneity. The relative
QRSr was derived from the proportion between QRS wave non-dipolar (4th-8th dimen-
sion) and total decomposition (1st-8th dimension) components of the QRS signal. This
index characterised depolarisation heterogeneity.
Results: QRSr value was significantly greater in 87 pts with RF compared with 70 pts
without any RF (0.48±0.47 v 0.29±0.22%, p=0.001). Pts with >2 RF (n=29) showed sig-
nificantly greater QRSr than pts without any RF (0.46±0.39 v 0.29±0.22%, p=0.03). Sig-
nificantly increased QRSr was found in pts with ABPR compared with those without
(0.62±0.40 vs 0.34±0.32%, p=0.003). Pts with MLVWT >30 mm tended to have greater
QRSr compared to those with MLVWT <30 mm (0.46±0.37 vs 0.40±0.39%, p=ns). No
association was found between QRSr and other single risk factors. No correlation was
found between QRSr and MLVWT (r=0.10, p=0.2) or any other echocardiographic indi-
ces. A weak and statistically significant correlation was found between QRSr and age (r=
-0.31, p=0.000). No gender difference was observed in this study.
Conclusions: Increased local electrical depolarisation heterogeneity exists in pts with
HC and RF compared with pts without any RF. Finding of an abnormally increased QRSr
indicates arrhythmia substrate in HC.
1072-217 QRS Intrinsicoid in Lead I: A Novel Surface 
Electrocardiogram Marker for Left Sided Conduction 
System Disease in Patients With a Right Bundle Branch 
Block Pattern
Behzad B. Pavri, Andrew Rudnick, Deepak Gaba, Reginald T. Ho, Arnold Greenspon, 
Thomas Jefferson University, Philadelphia, PA
Background: Cardiac resynchronization therapy (CRT) benefits heart failure patients
(pts) with left ventricular (LV) dysfunction and conduction system disease (CSD). LV pac-
ing in pts with left bundle branch block produces benefit by overcoming the delay in LV
activation caused by left sided CSD. It is not clear which patients with right bundle branch
block (RBBB) also have concomitant delay in LV activation, and therefore may benefit
from CRT. In pts with RBBB, a surface ECG marker of left sided CSD could prove helpful
in identifying those pts most likely to benefit from CRT.
Methods: We analyzed ECGs in 25 pts with RBBB who underwent electrophysiologic
study to determine who had co-existing left sided CSD. The HV interval was measured to
determine the conduction time through the left bundle branch. In lead I we measured
total QRS duration, and the duration of the initial rapid QRS depolarization forces (QRS
onset to the point on the S wave where dv/dt slows abruptly - the "intrinsicoid"). This
measurement reflects LV Purkinje network conduction time. The HV interval and the
intrinsicoid were correlated. An HV interval>55ms and QRS intrinsicoid>70% of total
QRS duration were considered abnormal.
Results: Study pts (20M,5F) had a mean age of 73±7 yrs, LVEF=0.51±0.13 (range 0.25-
0.75). Mean total QRS duration was 155±13ms (range 122-184ms) and mean intrinsicoid
was 93±23ms (range 61-162ms). The mean HV interval was 55±21ms (range 30-
130ms). There was a significant association between an HV>55ms, and intrinsicoid>70%
of total QRS duration (p<0.05, Student's t test). Linear regression identified a significant
correlation between the HV interval and the intrinsicoid (p<0.05, r=0.6). The correlation
between HV interval and total QRS duration was also significant, but weaker (p<0.05,
r=0.35).
Conclusions: In pts with RBBB, a prolonged HV interval, reflective of left bundle dis-
ease, is associated with a prolonged QRS intrinsicoid in lead I, reflective of Purkinje net-
work slowing. This suggests that the surface ECG finding of a prolonged intrinsicoid in
lead I >70% of total QRS duration may prove to be a useful non-invasive marker for iden-
tifying those pts with RBBB who are most likely to benefit from CRT.
1072-218 High Prevalence in Pharmacological Responses Mimic 
Brugada Syndrome in Japanese-A Pure Na Channel 
Blocker, Pilsicainide Challenge Test in the Normal Heart
Takeshi Ueyama, Akihiko Shimizu, Masahiro Esato, Ryousuke Kametani, Masashi 
Kanemoto, Noriko Inoue, Akira Sawa, Masunori Matsuzaki, Yamaguchi University School 
of Medicine, Ube, Japan
Background: Na channel blocker augments ST-segment elevation in the right precordial
leads in Brugada syndrome but its effect in general population is still unknown.
Subjects and Methods: After written informed consent was obtained, a pure Na channel
blocker, pilsicainide (PIL:1mg/kg; i.v. over 10 minutes), was administrated in consecutive
105 cases without identifiable structural abnormalities, or other conditions and agents
known to lead to ST-segment elevation in the right precordial leads (chest leads of V1-
V3). We characterized the ST-segment morphology and measured an increase of J-wave
amplitude in the right precordial leads. We picked up the maximum increase in J-wave
amplitude (max δJ) and investigated the distribution of the max δJ .
Results: Nobody showed the prominent coved ST-segment elevation displaying J-wave
amplitude or ST-segment elevation before PIL administration. PIL significantly increased
J-wave amplitude in general ( 140±82 to 310±197µV ). Furthermore, ECG developed the
distinct coved type ST-segment elevation in 35 cases (33%) and the biphasic distribution
pattern in max δJ was shown in a figure.
Conclusion: Based on the response of ST-segment to PIL, there were two groups, mild
and prominent ST-segment elevation to PIL in Japanese. In Japanese, the prevalence in
responses to Na channel blocker mimic that of Brugada syndrome might be relatively
higher than we expect. 
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807-1 Genetic and Biophysical Basis for Sudden Death in the 
Short QT Syndrome
Kui Hong, Robert Dumaine, Jonathan Cordeiro, Fiorenzo Gaita, Martin Borggrefe, Josep 
Brugada, Guido Pollevick, Christian Wolpert, Elena Burashnikov, Kiyotaka Matsuo, Yue 
Sheng Wu, Alejandra Guerchicoff, Francesca Bianchi, Carla Giustetto, Rainer Schimpf, 
Pedro Brugada, Charles Antzelevitch, Ramon Brugada, Masonic Medical Research 
Laboratory, Utica, NY
Background: The short QT syndrome is a newly described clinical entity that is charac-
terized by sudden death at a young age, short QT intervals in the electrocardiogram and
a structurally normal heart. The first publications indicated that it could be a genetic dis-
ease as it was present in different members of a same family.
Methods and results: We collected two unrelated families with hereditary short QT syn-
drome with a high degree of sudden cardiac death in their members. QT interval ranged
from 210 to 270 in the affected individuals. There was a high incidence of malignant
arrhythmias and sudden death in the families. Two individuals in one of the families had
an episode of sudden cardiac death, one of them aborted, before the first year of age,
indicating that short QT syndrome can also cause Sudden Infant Death Syndrome
(SIDS). We identified a different missense mutation in the two families (either C to A or C
to G substitution at nucleotide 1764) which resulted in the same amino acid change
Beck Depression Inventory (BDI)
BDI <6 (No 
Depressive 
Symptoms)
BDI 6-9 (Mild 
Depressive 
Symptoms)
BDI >10 (Moderate-
Severe Depressive 
Symptoms)
P Value
ULF 9.18 9.08 8.78 0.01
VLF 7.64 7.41 7.21 0.005
LF 6.80 6.40 6.38 0.02
HF 5.43 5.11 5.05 0.13
Total 
Power
9.49 9.35 9.10 0.005
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(N588K) in the pore forming region of the cardiac Kr channel (KCNH2, HERG). The
mutations dramatically increase IKr leading to heterogeneous abbreviation of action
potential duration and refractoriness and rendering the channel relatively unresponsive to
IKr blockers. Conclusion: Our data point to a novel genetic mechanism responsible for
sudden death in children, infants and young adults. The mutation leads to a heteroge-
neous abbreviation of action potential duration and refractoriness, creating the substrate
for reentrant arrhythmias.
9:30 a.m.
807-2 Selective Inhibition of Human Cardiac Kir2.2 Inward 
Rectifier Channels by Adrenergic Alpha-1a Receptors
Edgar Zitron, Claudia Kiesecker, Sonja Lück, Eberhard Scholz, Dierk Thomas, Sven 
Kathöfer, Volker A.W. Kreye, Wolfgang Schoels, Hugo A. Katus, Christoph A. Karle, 
University of Heidelberg Medical School, Heidelberg, Germany
Background:
Human Kir2.1 and Kir.2.2 potassium channels predominantly contribute to the molecular
basis of the cardiac inwardly rectifying potassium current IK1. Reduction of IK1 (as seen in
Andersen's syndrome and in congestive heart failure) causes delayed afterdepolariza-
tions which may result in premature ventricular beats and ventricular tachycardia. Inhibi-
tion of IK1 via activation of adrenergic alpha-1 receptors is a well-known phenomenon.
However, its molecular basis has not been elucidated yet. Therefore, we investigated the
interaction of alpha-1a receptors with Kir2.1 and Kir2.2 channels in the Xenopus oocyte
expression system.
Methods:
Cloned human adrenergic alpha-1a receptors and human Kir2.1 and Kir2.2 channels
were co-expressed in Xenopus oocytes and pharmacological experiments were per-
formed using the double electrode voltage clamp technique.
Results:
Application of phenylephrin (10 µM) to Xenopus oocytes expressing only Kir2.1 or Kir2.2
channels was without any effect. However, phenylephrin (10 µM) caused a significant
inhibition of Kir2.2 if the channels were co-expressed with adrenergic alpha-1a receptors.
Steady state conditions were reached after 30 minutes and current amplitudes were
reduced by 20 ± 5% compared to control measurements (p<0.05). In contrast, Kir2.1 cur-
rents were not affected by activation of the receptors.
Surprisingly, in Kir2.2 mutant channels lacking all protein kinase C (PKC) consensus
sites, the same effect as in the wild type could be observed.
Conclusion:
Our study demonstrates that adrenergic alpha-1a receptors exert an inhibitory effect on
human Kir2.2, but not Kir2.1 channels. The effect is independent of direct PKC mediated
phosphorylation of the channel protein. These findings elucidate the molecular basis of a
regulatory pathway which may contribute to the generation of ventricular arrhythmias in
congestive heart failure.
9:45 a.m.
807-3 Additional Gene Modifiers Reduce Effectiveness of β-
Blockers in the Long QT Type 1 Syndrome
Atsushi Kobori, Nobuaki Sarai, Wataru Shimizu, Satoshi Matsuoka, Akinori Noma, Toru 
Kita, Minoru Horie, Kyoto University Graduate School of Medicine, Kyoto, Japan, Shiga 
University of Medical Science, Otsu, Japan
Background:β-blockers are widely used to prevent the lethal cardiac events that associ-
ate long QT syndrome (LQTS) especially in KCNQ1-related LQTS (LQT1) patients.
Some LQT1 patients, however, are refractory to this therapy.
Methods and Results: Eighteen symptomatic LQTS patients (12 families) were geneti-
cally diagnosed to have heterozygous KCNQ1 variants and received β-blocker therapy.
Cardiac events recurred in 4 members (3 families) despite the continued therapy during
the mean follow-up period of 70 months. Three of them (2 families) had the same muta-
tion, A341V (KCNQ1), and the other had R243H (KCNQ1). The latter patient took aprind-
ine that seemed to be responsible for the event. Because A341V (KCNQ1) has not been
evaluated in heterologous mammalian expression system, we conducted functional anal-
ysis to investigate severe phenotype using COS7 cells. And we found that A341V
(KCNQ1) is a loss-of-function type mutation (not dominant negative) as well as previous
report in Xenopus oocytes. Further genetic screening revealed that one A341V (KCNQ1)
family cosegregated with S706C (KCNH2) and another with G144S (KCNJ2). Produced
functional outcome of S706C (KCNH2) mutation reduced current density with voltage
shift of activation kinetics. Action potential simulation study was conducted based on the
KYOTO model to estimate influences of additional gene modifiers. In both models mim-
icking LQT1 plus 2 and LQT1 plus 7, incidence of early afterdepolarization increased
compared with LQT1 model under the setting of β adrenergic stimulation.
Conclusion: Multiple mutations in different LQTS-related genes may modify the clinical
characteristics. Expanded gene survey might be required in the LQT1 patients who are
resistant to β-blocker therapy.
10:00 a.m.
807-4 CUG Expansions in a Myotonic Dystrophy Mouse Model 
Cause Cardiac Conduction Abnormalities and 
Pathologic Electrophysiology Findings
Cordula M. Wolf, Megan C. Sherwood, Dorothy Branco, Sita Reddy, Charles I. Berul, 
Children's Hospital, Boston, MA, University of Southern California School of Medicine, 
Los Angeles, CA
Background: Myotonic dystrophy (DM) is caused by a CTG trinucleotide expansion in
the 3’ untranslated region of the DM gene on chromosome 19. To assess the titration of
RNA-binding proteins by expanded RNA CUG sequences on cardiac function, we stud-
ied transgenic mice carrying long and short CTG repeats, expressing the RNA CUG
message at low (TGlow) and high (TGhigh) levels.
Methods: 14 TGhigh, 9 TGlow mice, and 6 age-matched wild-types (WT) underwent ECG
recordings, in vivo electrophysiology studies, and echocardiography.
Results: ECG measurements in sedated mice demonstrated significant PR, QRS and
QT prolongation in TGlow compared to WT mice. Right bundle branch block was seen in
16 of 22 TG versus 1 of 7 WT mice. Programmed pacing revealed inducible atrial fibrilla-
tion (2/19) and ventricular tachycardia (2/19) only in TG mice. Ventricular effective refrac-
tory period was longer in TG (TGlow: 63±9ms, TGhigh: 56±13ms) than in WT mice
(45±6ms, p<0.05). Echocardiography showed hypertrophic appearance only in TGhigh
mice, with a shorter end diastolic diameter and thicker left ventricular posterior wall diam-
eter (p<0.05).
Conclusion: Transgenic mice overexpressing CUG repeats displayed 1o heart block,
infraHisian conduction abnormalities, and arrhythmia vulnerability. These features were
more prominent in TGlow compared to TGhigh mice. Our study supports the hypothesis
that larger CTG expansions are associated with a higher risk of cardiac conduction dis-
ease in DM.
10:15 a.m.
807-5 Extracellular pH Modifies Drug Blockade on the Human 
Ether-A-Go-Go Related Gene (HERG) Channels
Lin Congrong, Ivana Cvetanovic, Vasant Ranade, John C. Somberg, Rush University, 
Chicago, IL
Background: HERG encodes the rapid component of delayed rectifier potassium current
(IKr), which is critical for the repolarization of cardiac action potentials. Significant change
in pH can occur during ischemia and reperfusion, and the effects of pH on IKr could be
an important underlying mechanism for arrhythmias.
Methods: We investigated the effect of external pH on IKr, as well as the influence of
external pH on the effect of IKr inhibition by anti-arrhythmia agents. HERG expressed in
Xenopus oocytes was used as the experimental model.
Results: Extracellular acidification decreased the amplitudes of both relatively small out-
ward currents and the large tail outward currents, while the decay of tail current was
accelerated. The steady state current was decreased by 14.4±6.8%, 19.8±10.4%,
23.8±10.4%, 28.3±10.5%, and the tail current was decreased by 6.7±1.1%, 8.7±2.1%,
13.4±1.5%, and 26.4±3.0% when decreasing pH from 8.0 to 7.4, 7.0, 6.6, and 6.2,
respectively. The effect of acidification and IKr inhibition by quinidine, dofetilide, and azi-
milide was evaluated. There was no additive or synergistic effect between extracellular
pH and antiarrhythmics on HERG. Quinidine 10 µM inhibited HERG tail current by
37.2±4.8% at pH 7.4. This inhibition was increased to 50.9±4.7% when extracellular pH
was 8.0 and decreased to 4.5±1.8% when extracellular pH was 6.2. Dofetilide 0.3 µM
inhibited HERG tail current by 64.4±7.4, 33.5±2.6 and 1.4±2.4% at extracellular pH 8.0,
7.4, and 6.2 respectively. Azimilide 10 µM inhibited HERG tail current by 63.0±3.6,
58.7±2.9 and 17.4±3.2% at extracellular pH 8.0, 7.4, and 6.2 respectively. For quinidine,
dofetilide, and azimilide, one way ANOVA test showed that there was a significant differ-
ence in current block among the different pH groups.
Conclusion: Our data suggests that extracellular acidification reduces HERG current.
The effects of quinidine, dofetilide, and azimilide are decreased at a more acid pH and
the block of IKr enhanced at a more alkaline pH.
ECG measurements in sedated mice
WT TGlow TGhigh One way 
ANOVA, p=
Post hoc Scheffe's 
analysis
SCL (ms) 131±6 142±7 143±19 ns ns
HR (bpm) 457±22 424±20 427±56 ns ns
PR (ms) 35.0±2.8* 41.2±5.5* 37.3±3.4 0.02 *: p=0.03
QRS (ms) 14.0±2.7 16.8±1.8* 13.7±2.5* 0.01 *: p=0.02
QT (ms) 21.7±2.1* 30.0±2.9*° 22.6±3.7° 0.000 *, °: p=0.000
QTc (ms) 19.0±2.2* 25.2±2.5*° 19.1±4.0° 0.000 *, °: p=0.000
